(Q24803928)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=55334

Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=55334

Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=55334

Challenges to therapy in the future

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=55334

Regular review: treatment of Helicobacter pylori infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=55334

Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=55334

Ranitidine bismuth citrate therapy regimens for treatment of Helicobacter pylori infection: a review.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=55334

Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=55334

Eradication of Helicobacter pylori in general practice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=55334

Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=55334

Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=55334

Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=55334

Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=55334

Eradication of Helicobacter pylori and non-ulcer dyspepsia

30 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-1-7

Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-1-7

One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-1-7

Rifabutin-based triple therapy after failure of Helicobacter pylori eradication treatment: preliminary experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-1-7

Ranitidine bismuth citrate can help to overcome Helicobacter pylori resistance to clarithromycin in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-1-7

Strategies to treat patients with antibiotic resistant Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-1-7

Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-1-7

Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=55334

Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group

28 November 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-1-7

Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-1-7

The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-1-7

Seven-day triple therapy with ranitidine bismuth citrate or omeprazole and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer: a multicentre, randomized, single-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-1-7

Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-1-7

Randomized study of two “rescue” therapies for helicobacter pylori-infected patients after failure of standard triple therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-1-7

Rifabutin-based 'rescue therapy' for Helicobacter pylori infected patients after failure of standard regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-1-7

Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth citrate-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-1-7

Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-1-7

Comparison of ranitidine bismuth citrate plus clarithromycin with omeprazole plus clarithromycin for the eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-1-7

Technical annex: tests used to assess Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11545677